{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:29:42Z","timestamp":1791804582141,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Noonan syndrome (NS) is a genetic disorder characterized by developmental delays, typical facial gestalt and cardiovascular defects.\n                      <jats:italic>LZTR1<\/jats:italic>\n                      variants have been recently described in patients with NS and schwannomatosis, but the association, inheritance pattern and management strategy has not been fully elucidated. Here, we review the contribution of\n                      <jats:italic>LZTR1<\/jats:italic>\n                      in NS and describe a patient with a novel, likely pathogenic variant in\n                      <jats:italic>LZTR1<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A female patient was diagnosed with clinical NS at 8\u00a0months of age. She presented in adulthood when a brain and spine MRI identified plexiform neurofibromas; however, she did not meet the clinical criteria for Neurofibromatosis type 1. No pathogenic variants were identified through molecular genetic analysis of\n                      <jats:italic>NF1<\/jats:italic>\n                      ,\n                      <jats:italic>SPRED1<\/jats:italic>\n                      and a multigene NS panel. Whole exome sequencing at age 23 identified a novel de novo likely pathogenic heterozygous variant in the\n                      <jats:italic>LZTR1<\/jats:italic>\n                      gene denoted as c.743G&gt;A (p.Gly248Glu). Serial MRIs have shown stable imaging findings and the patient is being followed clinically by cardiology, neurology and medical genetics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      We identified a novel mutation in the\n                      <jats:italic>LZTR1<\/jats:italic>\n                      gene, not previously reported in association with NS. This report provides additional evidence to support for the assessment of schwannomatosis in patients with\n                      <jats:italic>LZTR1<\/jats:italic>\n                      -NS and may have overlap with Neurofibromatosis type 1.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-022-01304-x","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T14:03:35Z","timestamp":1657893815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Kirsten M.","family":"Farncombe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Thain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Barnett-Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"issue":"3","key":"1304_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/ajmg.1320210312","volume":"21","author":"HM Mendez","year":"1985","unstructured":"Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet. 1985;21(3):493\u2013506.","journal-title":"Am J Med Genet"},{"key":"1304_CR2","unstructured":"Allanson JE, Roberts AM. Noonan syndrome. Available from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1124\/: GeneReviews; 2019."},{"issue":"3","key":"1304_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19(3):230\u20136.","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"1304_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7(4):295\u2013308.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1304_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/j.1349-7006.2009.01257.x","volume":"100","author":"T Matozaki","year":"2009","unstructured":"Matozaki T, Murata Y, Saito Y, Okazawa H, Ohnishi H. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci. 2009;100(10):1786\u201393.","journal-title":"Cancer Sci"},{"issue":"6","key":"1304_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jmedgenet-2015-103018","volume":"52","author":"GL Yamamoto","year":"2015","unstructured":"Yamamoto GL, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, et al. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet. 2015;52(6):413\u201321.","journal-title":"J Med Genet"},{"issue":"2","key":"1304_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng.2855","volume":"46","author":"A Piotrowski","year":"2014","unstructured":"Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, et al. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet. 2014;46(2):182\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"1304_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2019.01.007","volume":"63","author":"A Jacquinet","year":"2020","unstructured":"Jacquinet A, Bonnard A, Capri Y, Martin D, Sadzot B, Bianchi E, et al. Oligo-astrocytoma in LZTR1-related Noonan syndrome. Eur J Med Genet. 2020;63(1): 103617.","journal-title":"Eur J Med Genet"},{"issue":"8","key":"1304_CR9","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1074\/jbc.M509073200","volume":"281","author":"TG Nacak","year":"2006","unstructured":"Nacak TG, Leptien K, Fellner D, Augustin HG, Kroll J. The BTB-kelch protein LZTR-1 is a novel Golgi protein that is degraded upon induction of apoptosis. J Biol Chem. 2006;281(8):5065\u201371.","journal-title":"J Biol Chem"},{"issue":"10","key":"1304_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ng.2734","volume":"45","author":"V Frattini","year":"2013","unstructured":"Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, et al. The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet. 2013;45(10):1141\u20139.","journal-title":"Nat Genet"},{"issue":"10","key":"1304_CR11","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/gb-2005-6-10-r82","volume":"6","author":"PJ Stogios","year":"2005","unstructured":"Stogios PJ, Downs GS, Jauhal JJ, Nandra SK, Priv\u00e9 GG. Sequence and structural analysis of BTB domain proteins. Genome Biol. 2005;6(10):R82.","journal-title":"Genome Biol"},{"issue":"7","key":"1304_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327-41.e23.","journal-title":"Cell"},{"issue":"1","key":"1304_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00439-018-1951-7","volume":"138","author":"I Umeki","year":"2019","unstructured":"Umeki I, Niihori T, Abe T, Kanno SI, Okamoto N, Mizuno S, et al. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes. Hum Genet. 2019;138(1):21\u201335.","journal-title":"Hum Genet"},{"issue":"3","key":"1304_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41418-019-0395-5","volume":"27","author":"T Abe","year":"2020","unstructured":"Abe T, Umeki I, Kanno SI, Inoue SI, Niihori T, Aoki Y. LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. Cell Death Differ. 2020;27(3):1023\u201335.","journal-title":"Cell Death Differ"},{"issue":"6419","key":"1304_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.aap8210","volume":"362","author":"JW Bigenzahn","year":"2018","unstructured":"Bigenzahn JW, Collu GM, Kartnig F, Pieraks M, Vladimer GI, Heinz LX, et al. LZTR1 is a regulator of RAS ubiquitination and signaling. Science. 2018;362(6419):1171\u20137.","journal-title":"Science"},{"issue":"6419","key":"1304_CR16","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1126\/science.aap7607","volume":"362","author":"M Steklov","year":"2018","unstructured":"Steklov M, Pandolfi S, Baietti MF, Batiuk A, Carai P, Najm P, et al. Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. Science. 2018;362(6419):1177\u201382.","journal-title":"Science"},{"issue":"6","key":"1304_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/hmg\/ddy412","volume":"28","author":"M Motta","year":"2019","unstructured":"Motta M, Fidan M, Bellacchio E, Pantaleoni F, Schneider-Heieck K, Coppola S, et al. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling. Hum Mol Genet. 2019;28(6):1007\u201322.","journal-title":"Hum Mol Genet"},{"issue":"6432","key":"1304_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1126\/science.aav1444","volume":"363","author":"P Castel","year":"2019","unstructured":"Castel P, Cheng A, Cuevas-Navarro A, Everman DB, Papageorge AG, Simanshu DK, et al. RIT1 oncoproteins escape LZTR1-mediated proteolysis. Science. 2019;363(6432):1226\u201330.","journal-title":"Science"},{"issue":"7","key":"1304_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/ejhg.2014.220","volume":"23","author":"I Paganini","year":"2015","unstructured":"Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L, et al. Expanding the mutational spectrum of LZTR1 in schwannomatosis. Eur J Hum Genet. 2015;23(7):963\u20138.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"1304_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1212\/WNL.0000000000001129","volume":"84","author":"MJ Smith","year":"2015","unstructured":"Smith MJ, Isidor B, Beetz C, Williams SG, Bhaskar SS, Richer W, et al. Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis. Neurology. 2015;84(2):141\u20137.","journal-title":"Neurology"},{"issue":"3","key":"1304_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ajmg.1320210313","volume":"21","author":"JE Allanson","year":"1985","unstructured":"Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. Noonan syndrome: the changing phenotype. Am J Med Genet. 1985;21(3):507\u201314.","journal-title":"Am J Med Genet"},{"issue":"3","key":"1304_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ajmg.1320210310","volume":"21","author":"JM Opitz","year":"1985","unstructured":"Opitz JM, Weaver DD. The neurofibromatosis-Noonan syndrome. Am J Med Genet. 1985;21(3):477\u201390.","journal-title":"Am J Med Genet"},{"issue":"1","key":"1304_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4274\/jcrpe.galenos.2019.2019.0023","volume":"12","author":"E I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k E, Onay H, Atik T, Solmaz AE, \u00d6zen S, \u00c7o\u011fulu \u00d6, et al. A Neurofibromatosis Noonan syndrome patient presenting with abnormal external genitalia. J Clin Res Pediatr Endocrinol. 2020;12(1):113\u20136.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"1304_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1086\/498454","volume":"77","author":"A De Luca","year":"2005","unstructured":"De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, et al. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet. 2005;77(6):1092\u2013101.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1304_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.20023","volume":"119a","author":"D Baralle","year":"2003","unstructured":"Baralle D, Mattocks C, Kalidas K, Elmslie F, Whittaker J, Lees M, et al. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS). Am J Med Genet A. 2003;119a(1):1\u20138.","journal-title":"Am J Med Genet A"},{"issue":"24","key":"1304_CR26","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/ajmg.a.31547","volume":"140","author":"U H\u00fcffmeier","year":"2006","unstructured":"H\u00fcffmeier U, Zenker M, Hoyer J, Fahsold R, Rauch A. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene. Am J Med Genet A. 2006;140(24):2749\u201356.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1304_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12887-020-02102-z","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Chen X, Zhou R, Yin H, Xu J. Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1\u201358 deletion: a case report. BMC Pediatr. 2020;20(1):190.","journal-title":"BMC Pediatr"},{"issue":"3","key":"1304_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00576.x","volume":"69","author":"DA Stevenson","year":"2006","unstructured":"Stevenson DA, Viskochil DH, Rope AF, Carey JC. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet. 2006;69(3):246\u201353.","journal-title":"Clin Genet"},{"issue":"3","key":"1304_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ajmg.a.30813","volume":"136","author":"DR Bertola","year":"2005","unstructured":"Bertola DR, Pereira AC, Passetti F, de Oliveira PS, Messiaen L, Gelb BD, et al. Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. Am J Med Genet A. 2005;136(3):242\u20135.","journal-title":"Am J Med Genet A"},{"key":"1304_CR30","doi-asserted-by":"crossref","unstructured":"D'Amico A, Rosano C, Pannone L, Pinna V, Assunto A, Motta M, et al. Clinical variability of neurofibromatosis 1: a modifying role of cooccurring PTPN11 variants and atypical brain MRI findings. Clin Genet. 2021.","DOI":"10.1111\/cge.14040"},{"issue":"6","key":"1304_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1399-0004.2009.01233.x","volume":"76","author":"AM Nystr\u00f6m","year":"2009","unstructured":"Nystr\u00f6m AM, Ekvall S, Allanson J, Edeby C, Elinder M, Holmstr\u00f6m G, et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet. 2009;76(6):524\u201334.","journal-title":"Clin Genet"},{"issue":"11","key":"1304_CR32","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1002\/ajmg.a.35519","volume":"158a","author":"AC Malaquias","year":"2012","unstructured":"Malaquias AC, Brasil AS, Pereira AC, Arnhold IJ, Mendonca BB, Bertola DR, et al. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS\/MAPK pathway. Am J Med Genet A. 2012;158a(11):2700\u20136.","journal-title":"Am J Med Genet A"},{"issue":"8","key":"1304_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/gim.2014.160","volume":"17","author":"K Retterer","year":"2015","unstructured":"Retterer K, Scuffins J, Schmidt D, Lewis R, Pineda-Alvarez D, Stafford A, et al. Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort. Genet Med. 2015;17(8):623\u20139.","journal-title":"Genet Med"},{"issue":"5","key":"1304_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"2","key":"1304_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249\u201355.","journal-title":"Genet Med"},{"issue":"7","key":"1304_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565\u201374.","journal-title":"Genet Med"},{"issue":"10","key":"1304_CR37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/gim.2017.249","volume":"20","author":"JJ Johnston","year":"2018","unstructured":"Johnston JJ, van der Smagt JJ, Rosenfeld JA, Pagnamenta AT, Alswaid A, Baker EH, et al. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet Med. 2018;20(10):1175\u201385.","journal-title":"Genet Med"},{"issue":"6","key":"1304_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/cge.13533","volume":"95","author":"AT Pagnamenta","year":"2019","unstructured":"Pagnamenta AT, Kaisaki PJ, Bennett F, Burkitt-Wright E, Martin HC, Ferla MP, et al. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome. Clin Genet. 2019;95(6):693\u2013703.","journal-title":"Clin Genet"},{"issue":"9","key":"1304_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/pd.5497","volume":"39","author":"T Weissbach","year":"2019","unstructured":"Weissbach T, Kushnir A, Rasslan R, Rosenblatt O, Yinon Y, Berkenstadt M, et al. Fetal pleural effusion: contemporary methods of genetic evaluation. Prenat Diagn. 2019;39(9):751\u20137.","journal-title":"Prenat Diagn"},{"issue":"7616","key":"1304_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391.","journal-title":"Nature"},{"issue":"10","key":"1304_CR41","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41431-020-0658-0","volume":"28","author":"L Ferrari","year":"2020","unstructured":"Ferrari L, Mangano E, Bonati MT, Monterosso I, Capitanio D, Chiappori F, et al. Digenic inheritance of subclinical variants in Noonan Syndrome patients: an alternative pathogenic model? Eur J Hum Genet. 2020;28(10):1432\u201345.","journal-title":"Eur J Hum Genet"},{"key":"1304_CR42","doi-asserted-by":"crossref","unstructured":"Ghedira N, Kraoua L, Lagarde A, Abdelaziz RB, Olschwang S, Desvignes JP, et al. Further evidence for the implication of LZTR1, a gene not associated with the Ras-Mapk pathway, in the pathogenesis of Noonan syndrome. Biol Med. 2017;9(6).","DOI":"10.4172\/0974-8369.1000414"},{"issue":"1","key":"1304_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-019-1010-z","volume":"14","author":"H Chen","year":"2019","unstructured":"Chen H, Li X, Liu X, Wang J, Zhang Z, Wu J, et al. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort. Orphanet J Rare Dis. 2019;14(1):29.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1304_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12902-020-00666-6","volume":"21","author":"X Zhao","year":"2021","unstructured":"Zhao X, Li Z, Wang L, Lan Z, Lin F, Zhang W, et al. A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review. BMC Endocr Disord. 2021;21(1):2.","journal-title":"BMC Endocr Disord"},{"issue":"11","key":"1304_CR45","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.recesp.2019.04.007","volume":"72","author":"F Perin","year":"2019","unstructured":"Perin F, Trujillo-Quintero JP, Jimenez-Jaimez J, Rodr\u00edguez-V\u00e1zquez Del Rey MDM, Monserrat L, Tercedor L. Two novel cases of autosomal recessive Noonan syndrome associated with LZTR1 variants. Rev Esp Cardiol (Engl Ed). 2019;72(11):978\u201380.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"1304_CR46","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41436-018-0041-5","volume":"21","author":"M Nakaguma","year":"2019","unstructured":"Nakaguma M, Jorge AAL, Arnhold IJP. Noonan syndrome associated with growth hormone deficiency with biallelic LZTR1 variants. Genet Med. 2019;21(1):260.","journal-title":"Genet Med"},{"issue":"4","key":"1304_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000502741","volume":"92","author":"M G\u00fcemes","year":"2019","unstructured":"G\u00fcemes M, Mart\u00edn-Rivada \u00c1, Ortiz-Cabrera NV, Martos-Moreno G, Pozo-Rom\u00e1n J, Argente J. LZTR1: genotype expansion in Noonan syndrome. Horm Res Paediatr. 2019;92(4):269\u201375.","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"1304_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/01.wco.0000044763.39452.aa","volume":"15","author":"RE Ferner","year":"2002","unstructured":"Ferner RE, O\u2019Doherty MJ. Neurofibroma and schwannoma. Curr Opin Neurol. 2002;15(6):679\u201384.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"1304_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/BSD.0b013e318033ee0f","volume":"20","author":"FD Westhout","year":"2007","unstructured":"Westhout FD, Mathews M, Par\u00e9 LS, Armstrong WB, Tully P, Linskey ME. Recognizing schwannomatosis and distinguishing it from neurofibromatosis type 1 or 2. J Spinal Disord Tech. 2007;20(4):329\u201332.","journal-title":"J Spinal Disord Tech"},{"issue":"1","key":"1304_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12887-021-02791-0","volume":"21","author":"E Pinti","year":"2021","unstructured":"Pinti E, Nemeth K, Staub K, Lengyel A, Fekete G, Haltrich I. Diagnostic difficulties and possibilities of NF1-like syndromes in childhood. BMC Pediatr. 2021;21(1):331.","journal-title":"BMC Pediatr"},{"issue":"6","key":"1304_CR51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1399-0004.2011.01764.x","volume":"81","author":"DR Bertola","year":"2012","unstructured":"Bertola DR, Pereira AC, Brasil AC, Suzuki L, Leite C, Falzoni R, et al. Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship? Clin Genet. 2012;81(6):595\u20137.","journal-title":"Clin Genet"},{"issue":"4","key":"1304_CR52","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/513207","volume":"80","author":"TJ Hulsebos","year":"2007","unstructured":"Hulsebos TJ, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P. Germline mutation of INI1\/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80(4):805\u201310.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"1304_CR53","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1158\/1078-0432.CCR-17-0590","volume":"23","author":"DGR Evans","year":"2017","unstructured":"Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, et al. Cancer and central nervous system tumor surveillance in pediatric Neurofibromatosis 2 and related disorders. Clin Cancer Res. 2017;23(12):e54\u201361.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1304_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ajmg.a.37379","volume":"170a","author":"GD McWilliams","year":"2016","unstructured":"McWilliams GD, SantaCruz K, Hart B, Clericuzio C. Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy. Am J Med Genet A. 2016;170a(1):195\u2013201.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"1304_CR55","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1210\/jc.2008-2094","volume":"94","author":"AA Romano","year":"2009","unstructured":"Romano AA, Dana K, Bakker B, Davis DA, Hunold JJ, Jacobs J, et al. Growth response, near-adult height, and patterns of growth and puberty in patients with Noonan syndrome treated with growth hormone. J Clin Endocrinol Metab. 2009;94(7):2338\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1304_CR56","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/j.1651-2227.2005.tb02081.x","volume":"94","author":"D Osio","year":"2005","unstructured":"Osio D, Dahlgren J, Wikland KA, Westphal O. Improved final height with long-term growth hormone treatment in Noonan syndrome. Acta Paediatr. 2005;94(9):1232\u20137.","journal-title":"Acta Paediatr"},{"issue":"5","key":"1304_CR57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1525-1470.2011.01641.x","volume":"29","author":"D Moos","year":"2012","unstructured":"Moos D, Droitcourt C, Rancherevince D, Marec Berard P, Skowron F. Atypical granular cell tumor occurring in an individual with Noonan syndrome treated with growth hormone. Pediatr Dermatol. 2012;29(5):665\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"1304_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104372","volume":"65","author":"CM Wolf","year":"2022","unstructured":"Wolf CM, Zenker M, Burkitt-Wright E, Edouard T, Garc\u00eda-Mi\u00f1a\u00far S, Lebl J, et al. Management of cardiac aspects in children with Noonan syndrome - results from a European clinical practice survey among paediatric cardiologists. Eur J Med Genet. 2022;65(1): 104372.","journal-title":"Eur J Med Genet"},{"issue":"11","key":"1304_CR59","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/humu.23624","volume":"39","author":"AR Grant","year":"2018","unstructured":"Grant AR, Cushman BJ, Cav\u00e9 H, Dillon MW, Gelb BD, Gripp KW, et al. Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. Hum Mutat. 2018;39(11):1485\u201393.","journal-title":"Hum Mutat"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-022-01304-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:41:07Z","timestamp":1700826067000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-022-01304-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1186\/s12920-022-01304-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is in approval with the University Health Network Ethics Committee. Written informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent for publication of a case report was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CBT has been a consultant for Alexion, CSL, Takeda, Sanofi and has received research grants from Grifols and Octapharma, not related to this work. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}